Assessment of soluble cell adhesion molecules and soluble CD40 ligand levels in ankylosing spondylitis.
Sari
Ismail
I
Alacacioglu
Ahmet
A
Kebapcilar
Levent
L
Taylan
Ali
A
Bilgir
Oktay
O
Yildiz
Yasar
Y
Yuksel
Arif
A
Kozaci
Didem L
DL
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D023201:CD40 Ligand / Q000097:blood*; D015815:Cell Adhesion Molecules / Q000097:blood*; D004359:Drug Therapy, Combination; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D013167:Spondylitis, Ankylosing / Q000097:blood* / Q000188:drug therapy / Q000503:physiopathology; D012460:Sulfasalazine / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D015415:Biomarkers; D015815:Cell Adhesion Molecules; D007155:Immunologic Factors; D014409:Tumor Necrosis Factor-alpha; D023201:CD40 Ligand; D012460:Sulfasalazine